BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9416974)

  • 21. Functional analysis of pyrimidine biosynthesis enzymes using the anticancer drug 5-fluorouracil in Caenorhabditis elegans.
    Kim S; Park DH; Kim TH; Hwang M; Shim J
    FEBS J; 2009 Sep; 276(17):4715-26. PubMed ID: 19645718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between short or long exposure to 5-fluorouracil in human gastric and colon cancer cell lines: biochemical mechanism of resistance.
    Harstrick A; Gonzales A; Schleucher N; Vanhoefer U; Lu K; Formento JL; Milano G; Wilke H; Seeber S; Rustum Y
    Anticancer Drugs; 1998 Aug; 9(7):625-34. PubMed ID: 9773807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study.
    Fanciullino R; Evrard A; Cuq P; Giacometti S; Peillard L; Mercier C; Aubert C; Milano G; Ciccolini J
    Anticancer Drugs; 2006 Apr; 17(4):463-70. PubMed ID: 16550005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
    Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells.
    Temmink OH; de Bruin M; Comijn EM; Fukushima M; Peters GJ
    Anticancer Drugs; 2005 Mar; 16(3):285-92. PubMed ID: 15711180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
    Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ
    World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY; Lee JS; Min HY; Lee HY
    Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil.
    Copur S; Aiba K; Drake JC; Allegra CJ; Chu E
    Biochem Pharmacol; 1995 May; 49(10):1419-26. PubMed ID: 7763285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism for resistance to 5-fluorouracil in P388 leukemia cells.
    Mitsuhashi J; Inaba M
    J Pharmacobiodyn; 1991 Oct; 14(10):577-81. PubMed ID: 1818099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells.
    Mori R; Yoshida K; Futamura M; Suetsugu T; Shizu K; Tanahashi T; Tanaka Y; Matsuhashi N; Yamaguchi K
    Gastric Cancer; 2019 May; 22(3):497-505. PubMed ID: 30276573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of response to antimetabolites and their modulation by normal purine and pyrimidine metabolites.
    Rustum YM; Danhauser L; Luccioni C; Au JL
    Cancer Treat Rep; 1981; 65 Suppl 3():73-82. PubMed ID: 7049369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
    Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
    Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
    Banerjee D; Mayer-Kuckuk P; Capiaux G; Budak-Alpdogan T; Gorlick R; Bertino JR
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):164-73. PubMed ID: 12084458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzylacyclouridine enhances 5-fluorouracil cytotoxicity against human prostate cancer cell lines.
    Yee LK; Chu E; Pan BC; Chu SH; Chen TM; Lipsky MH; Chu MY; Calabresi P
    Pharmacology; 1998 Feb; 56(2):80-91. PubMed ID: 9494066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase.
    Correale P; Sabatino M; Cusi MG; Micheli L; Nencini C; Pozzessere D; Petrioli R; Aquino A; De Vecchis L; Turriziani M; Prete SP; Sanguedolce R; Rausa L; Giorgi G; Francini G
    J Chemother; 2001 Oct; 13(5):519-26. PubMed ID: 11760216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Thymidine Phosphorylase Gene Demethylation on Sensitivity to 5-Fluorouracil in Colorectal Cancer Cells.
    Koyama M; Osada E; Akiyama N; Eto K; Manome Y
    Anticancer Res; 2022 Feb; 42(2):837-844. PubMed ID: 35093881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.